J9034 HCPCS code: Injection, bendamustine hcl (bendeka), 1 mg
J9034 is the HCPCS Level II code for injection, bendamustine hcl (bendeka), 1 mg. In 2024 Medicare paid an average of $10.75 per service for J9034 across 1,365,439 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 360 per day on outpatient hospital claims. Medicare volume fell 38% from 2022 to 2024 (2,196,056 to 1,365,439 services). In 2024, about 1,599 clinicians billed Medicare for J9034 for 1,350 beneficiaries; Texas, California, Virginia accounted for 36% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2017-01-01 |
| Last action effective | 2017-01-01 |
Who bills J9034 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,599 |
| Medicare beneficiaries | 1,350 |
| States with claims | 24 |
| Share of services in top 3 states (Texas, California, Virginia) | 36% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9034, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 2,196,056 | 2,159 | $17.99 | $14.36 |
| 2023 | 1,797,514 | 1,763 | $16.20 | $12.90 |
| 2024 | 1,365,439 | 1,350 | $13.50 | $10.75 |
States with the most J9034 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 222,416 | $10.78 |
| California | 135,629 | $10.75 |
| Virginia | 95,829 | $10.71 |
| Arizona | 90,691 | $10.66 |
| Minnesota | 87,654 | $10.81 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 360 | Prescribing Information |
| practitioner claims | 360 | Prescribing Information |
What changed for J9034
- 2017-01-01: J9034 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9034?
J9034 is the HCPCS Level II code for injection, bendamustine hcl (bendeka), 1 mg. Short descriptor: "Inj., bendeka 1 mg".
How much does Medicare pay for J9034?
In 2024, the average Medicare payment was $10.75 per service (average allowed $13.50).
Does Medicare cover J9034?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9034 can be billed per day?
360 on outpatient hospital claims; 360 on practitioner claims (NCCI medically unlikely edits).
Related J90 codes
- J9000 — Injection, doxorubicin hydrochloride, 10 mg
- J9010 — Injection, alemtuzumab, 10 mg
- J9011 — Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 — Injection, aldesleukin, per single use vial
- J9017 — Injection, arsenic trioxide, 1 mg
- J9019 — Injection, asparaginase (erwinaze), 1,000 iu
- J9020 — Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 — Injection, atezolizumab, 10 mg
- J9023 — Injection, avelumab, 10 mg
- J9024 — Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025 — Injection, azacitidine, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9034
- Watch J9034 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9034
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.